Abcam is a life sciences company that identifies and develops biological reagents and tools. The company provides antibodies, binders, and assays, including primary and secondary antibodies, ELISA and matched antibody pairs, knockout cell lines and lysates, multiplex assays, agonists, antagonists, activators, inhibitors, as well as proteins and peptides. Its products are applicable in research, drug discovery, and diagnostics.
Revenue growth (FY, 2019 - FY, 2020), %
Gross profit (FY, 2020)
Gross profit margin (FY, 2020), %
Net income (FY, 2020)
EBIT (FY, 2020)
Market capitalization (30-Mar-2021)
Closing stock price (30-Mar-2021)
|Company Name||Date||Deal Size|
|Abcam Trading (Shanghai) Co. Ltd.|
|Abcam US Group Holdings Inc.|
|Abcam (US) Ltd.|
Abcam revenue breakdown by business segment: 93.5% from Catalogue and 6.5% from Custom Products and Licensing
Abcam revenue breakdown by geographic segment: 43.2% from The Americas, 26.7% from EMEA, 15.2% from China, 7.2% from Japan and 7.7% from Rest of Asia Pacific
Abcam has 6.99k Twitter Followers. The number of followers has increased 1.5% month over month and increased 3.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Abcam founded?
Abcam was founded in 1998.
Who are Abcam key executives?
Abcam's key executives are Alan Hirzel, Peter Allen and Jonathan Milner.
How many employees does Abcam have?
Abcam has 1,492 employees.
What is Abcam revenue?
Latest Abcam annual revenue is £260 m.
What is Abcam revenue per employee?
Latest Abcam revenue per employee is £174.3 k.
Who are Abcam competitors?
Competitors of Abcam include BioLegend, Bio-Techne and Humanigen.
Where are Abcam offices?
Abcam has offices in Branford, Burlingame, Cambridge, Eugene and in 4 other locations.
How many offices does Abcam have?
Abcam has 8 offices.
Receive alerts for 300+ data fields across thousands of companies